|
[1]
|
World Health Organization (2017) Depression and Other Common Mental Disorders: Global Estimates.
|
|
[2]
|
American Psychological Association (2000) Diagnostic and Statistical Manual of Mental Disorders.
|
|
[3]
|
阎丹峰, 李凌江. 抑郁症患者的认知功能障碍及其临床启示[J]. 中华精神科杂志, 2018, 51(5): 343-346.
|
|
[4]
|
Afridi, M.I., Hina, M., Qureshi, I.S., et al. (2011) Cognitive Disturbance Comparison among Drug-Naive Depressed Cases and Healthy Controls. Journal of College of Physicians and Surgeons Pakistan, 21, 351-355.
|
|
[5]
|
Vicent-Gil, M., Keymer-Gausset, A., Serra-Blasco, M., et al. (2018) Cognitive Predictors of Illness Course at 12 Months after First-Episode of Depression. European Neuropsychopharmacology, 28, 529-537. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Rock, P.L., Roiser, J.P., Riedel, W.J., et al. (2014) Cognitive Impairment in Depression: A Systematic Review and Meta-Analysis. Psychological Medicine, 44, 2029-2040. [Google Scholar] [CrossRef]
|
|
[7]
|
Conradi, H.J., Ormel, J. and De Jonge, P. (2011) Presence of Individual (Residual) Symptoms during Depressive Episodes and Periods of Remission: A 3-Year Prospective Study. Psychological Medicine, 41, 1165-1174. [Google Scholar] [CrossRef]
|
|
[8]
|
Cheng, Y.C., Liu, S.I., Chen, C.H., et al. (2020) Comparison of Cognitive Function between Early- and Late-Onset Late-Life Depression in Remission. Psychiatry Research, 290, Article ID: 113051. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Borroto-Escuela, D.O., Ambrogini, P., Chruścicka, B., et al. (2021) The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects. International Journal of Molecular Sciences, 22, 1927. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
徐爱军, 刘昊, 刘英, 等. 抑郁症大鼠海马体积异常的形态学探讨[J]. 中风与神经疾病杂志, 2014, 31(2): 118-120.
|
|
[11]
|
Fakhoury, M. (2016) Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders. Molecular Neurobiology, 53, 2778. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
刘佳丽, 王亮. 抑郁症认知功能损伤及异常脑机制研究进展[J]. 科学通报, 2018(20): 1973-1983.
|
|
[13]
|
刘丽, 吕新, 周生, 等. 选择性5-羟色胺再摄取抑制剂对抑郁症患者认知障碍的影响.[J]. 中国药业, 2018, 27(20): 37-40.
|
|
[14]
|
Mahableshwarkar, A.R., Zajecka, J., Jacobson, W., et al. (2015) A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. Neuropsychopharmacology, 40, 2025-2037. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Sagud, M., Nikolac Perkovic, M., Dvojkovic, A., et al. (2021) Distinct Association of Plasma BDNF Concentration and Cognitive Function in Depressed Patients Treated with Vortioxetine or Escitalopram. Psychopharmacology (Berl), 238, 1575-1584. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Nierenberg, A.A., Loft, H. and Olsen, C.K. (2019) Treatment Effects on Residual Cognitive Symptoms among Partially or Fully Remitted Patients with Major Depressive Disorder: A Randomized, Double-Blinded, Exploratory Study with Vortioxetine. Journal of Affective Disorders, 250, 35-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Soczynska, J.K., Ravindran, L.N., Styra, R., et al. (2014) The Effect of Bupropion XL and Escitalopram on Memory and Functional Outcomes in Adults with Major Depressive Disorder: Results from a Randomized Controlled Trial. Psychiatry Research, 220, 245-250. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Amanathan, M., Kumar, S.N. and Suresh, B. (2003) Evaluation of Cognitive Function of fluoxetine, Sertraline and Tianeptine in Isolation and Chronic Unpredictable Mild Stress-Induced Depressive Wistar Rats. Indian Journal of Experimental Biology, 41, 1269-1272.
|
|
[19]
|
Herzallah, M.M., Moustafa, A.A., Natsheh, J.Y., et al. (2013) Depression Impairs Learning, Whereas the Selective Serotonin Reuptake Inhibitor, Paroxetine, Impairs Generalization in Patients with Major Depressive Disorder. Journal of Affective Disorders, 151, 484-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yu, L., An, C., et al. (2016) Combination Therapy of Salvianolic Acid and Fluoxetine Improves the Cognitive Function of Rats with Chronic Stress-induced Depression. World Neurosurgery, 86, 173-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ehrson, A.L., Leiser, S.C., Gulinello, M., et al. (2015) Treatment of Cognitive Dysfunction in Major Depressive Disorder—A Review of the Preclinical Evidence for Efficacy of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and the Multimodal-Acting Antidepressant Vortioxetine. European Journal of Pharmacology, 753, 19-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Baune Bernhard, T. and Renger, L. (2014) Pharmacological and Non-Pharmacological Interventions to Improve Cognitive Dysfunction and Functional Ability in Clinical Depression—A Systematic Review. Psychiatry Research, 219, 25-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kennedy, S.H., Lam, R.W., McIntyre, R.S., et al. (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. The Canadian Journal of Psychiatry, 61, 540-560. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Dai, M.H., Li, D.Q. and Han, Y. (2011) Effect of Venlafaxine on Cognitive Function and Hippocampal Brain-Derived Neurotrophic Factor Expression in Rats with Post-Stroke Depression. Journal of Zhejiang University. Medical Sciences, 40, 527-534.
|
|
[25]
|
Tian, Y., Du, J., Spagna, A., Mackie, M.A., et al. (2016) Venlafaxine Treatment Reduces the Deficit of Executive Control of Attention in Patients with Major Depressive Disorder. Scientific Reports, 6, Article No. 28028. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Shiyansky, C., Williams, L.M., Gyurak, A., et al. (2016) Effect of Antidepressant Treatment on Cognitive Impairments Associated with Depression: A Randomized Longitudinal Study. The Lancet Psychiatry, 3, 425-435. [Google Scholar] [CrossRef]
|
|
[27]
|
Nagane, A., Baba, H., Nakano, Y., et al. (2014) Comparative Study of Cognitive Impairment between Medicated and Medication-Free Patients with Remitted Major Depression: Class-Specific Influence by Tricyclic Antidepressants and Newer Antidepressants. Psychiatry Research, 218, 101-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Soczynska, J.K., Ravindran, L.N., Styra, R., et al. (2014) The Effect of Bupropion XL and Escitalopram on Memory and Functional Outcomes in Adults with Major Depressive Disorder: Results from a Randomized Controlled Trial. Psychiatry Research, 220, 245-250. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Medvedev, V.E., Ter-Israelyan, A.Y., Frolova, V.I., et al. (2018) Treatment of Depression with Cognitive Impairment. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 118, 77-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Gregory, E., Torres, I.J., Ge, R., et al. (2020) Predictors of Cognitive Impairment in Treatment-Resistant Depression. Journal of Affective Disorders, 274, 593-601. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Peciña, M., Karp, J.F., Mathew, S., et al. (2019) Endogenous Opioid System Dysregulation in Depression: Implications for New Therapeutic Approaches. Molecular Psychiatry, 24, 576-587. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Varastehmoradi, B., Wegener, G., Sanchez, C., et al. (2020) Opioid System Modulation of Cognitive Affective Bias: Implications for the Treatment of Mood Disorders. Behavioural Pharmacology, 31, 122-135. [Google Scholar] [CrossRef]
|
|
[33]
|
Jacobson, M.L., Wulf, H.A., Browne, C.A., et al. (2018) Opioid Modulation of Cognitive Impairment in Depression. Progress in Brain Research, 239, 1-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Liu, X., Hao, J., Yao, E., et al. (2020) Polyunsaturated Fatty Acid Supplement Alleviates Depression-Incident Cognitive Dysfunction by Protecting the Cerebrovascular and Glymphatic Systems. Brain, Behavior, and Immunity, 89, 357-370. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Araújo-de-Freitas, L., Santos-Lima, C., Mendonça-Filho, E., et al. (2021) Neurocognitive Aspects of Ketamine and Esketamine on Subjects with Treatment-Resistant Depression: A Comparative, Randomized and Double-Blind Study. Psychiatry Research, 303, Article ID: 114058. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Cha, D.S., Best, M.W., Bowie, C.R., et al. (2017) A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Mood in Individuals with Treatment-Resistant Major Depressive Disorder. Journal of Affective Disorders, 210, 57-65. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Iskra, D.A. and Butko, D.Y. (2020) Pain, Emotion, Cognition. Pathogenetic Relationships and Effects of Therapy with Nonsteroidal Anti-Inflammatory Drugs. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 120, 51-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ramon-Duaso, C., Gener, T., Consegal, M., et al. (2019) Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression. Cerebral Cortex, 29, 2978-2997. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Kavanaugh, B.C., Aaronson, S.T., Clarke, G.N., et al. (2018) Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation with a 2-Coil Device in Treatment-Resistant Major Depressive Disorder. The Journal of ECT, 34, 258-265. [Google Scholar] [CrossRef]
|
|
[40]
|
Tateishi, H., Mizoguchi, Y., Kawaguchi, A., et al. (2020) Changes in Interleukin-1 Beta Induced by rTMS Are Significantly Correlated with Partial Improvement of Cognitive Dysfunction in Treatment-Resistant Depression: A Pilot Study. Psychiatry Research, 289, Article ID: 112995. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Su, L., Jia, Y., Liang, S., et al. (2019) Multicenter Randomized Controlled Trial of Bifrontal, Bitemporal, and Right Unilateral Electroconvulsive Therapy in Major Depressive Disorder. Psychiatry and Clinical Neurosciences, 73, 636-641. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Tian, H., Li, G., Xu, G., et al. (2021) Inflammatory Cytokines Derived from Peripheral Blood Contribute to the Modified Electroconvulsive Therapy-Induced Cognitive Deficits in Major Depressive Disorder. European Archives of Psychiatry and Clinical Neuroscience, 271, 475-485. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Du, L., Qiu, H., Liu, H., et al. (2016) Changes in Problem-Solving Capacity and Association with Spontaneous Brain Activity after a Single Electroconvulsive Treatment in Major Depressive Disorder. The Journal of ECT, 32, 49-54. [Google Scholar] [CrossRef]
|
|
[44]
|
王虎, 谢雯, 王安珍. 电休克治疗对抑郁症患者认知功能的短期和长期影响[J]. 中国药物依赖性杂志, 2019, 28(1): 59-64.
|
|
[45]
|
谢新凤, 李德波, 邓书禄, 等. 计算机认知矫正治疗对抑郁症患者记忆功能的影响[J]. 中国健康心理学杂志, 2020(7): 967-971.
|
|
[46]
|
Hargreaves, A., Daly-Ryan, N., Dillon, R., et al. (2018) Independent Computerized Cognitive Remediation for Psychosis: An Investigation of Patient Experiences. The Journal of Nervous and Mental Disease, 206, 606-613. [Google Scholar] [CrossRef]
|
|
[47]
|
姚烨, 杨春燕, 许艳秋, 等. 认知行为治疗对老年抑郁症患者认知功能改善的对照观察[J]. 国际精神病学杂志, 2020(1): 67-70.
|
|
[48]
|
陈帅, 刘素芳, 郜珍妮, 等. 认知行为治疗联合社会性支持治疗对老年抑郁症患者认知功能、社会支持及抑郁程度的影响[J]. 临床研究, 2021(8): 63-64.
|